Concepedia

Francesco Atzori

FA

Statistics

Publications

57

Citations

3.7K

H-Index

29

Active since

1994

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

University of Cagliari

Fondazione IRCCS Istituto Nazionale dei Tumori

University of Parma

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Francesco Atzori is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

1994–2024

57

Publications

57

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

Violeta Serra, Ben Markman, Maurizio Scaltriti et al. · Cancer Research · 2008 · 796 citations · Full text

, , +16

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 415 citations · Full text

, , +16

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini et al. · The Oncologist · 2019 · 221 citations · Full text

, , +17

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

Alessio Cortellini, Rita Chiari, Biagio Ricciuti et al. · Clinical Lung Cancer · 2019 · 179 citations

, , +16

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

Andreas Wollenberg, Sakari Reitamo, Francesco Atzori et al. · Allergy · 2008 · 130 citations

, , +13

1–5 of 57